อาจารย์ ดร. เภสัชกรหญิงศรีวรรณ ธีระมั่นคง

 


อาจารย์ประจำสาขาวิชาวิทยาศาสตร์เภสัชกรรม


Field of Interest :
1. Drug design, synthesis of novel compounds and their applications in the field of Medicinal Chemistry (anticancer agents, antidiabetic agents)
2. Pharmaceutical quality control, the analytical method development and method validation (HPLC)
3. Molecular modeling design (AutoDock)

sewan@tu.ac.th,    sewan_t@yahoo.com

ประวัติการศึกษา :

คุณวุฒิ สาขา ปีที่จบ ชื่อสถานศึกษา
ภ.บ. เภสัชศาสตร์ 2541 จุฬาลงกรณ์มหาวิทยาลัย
ภ.ม. Pharmaceutical chemistry 2552 มหาวิทยาลัยมหิดล
Ph.D. Medicinal Chemistry 2556 Università degli Studi del Piemonte Orientale, Italy

 

ผลงานวิจัยตีพิมพ์ :

1. “Iridium-Catalyzed Cycloaddition of Azides and 1-Bromoalkynes at Room Temperature” Rasalofonjatovo, E.; Theeramunkong, S.; Bouriaud, A.; Kolodych, S.; Chaumontet, M. and Taran. F. Org.Lett., 2013, 15(18), 4698-4701.
2. “Parallel synthesis of “click” chalcones as antitubulin agents.” Utsintong, M.; Massarotti, A. Caldarelli, A.; Theeramunkong, S.*, Med. Chem., 2013, 9(4), 510-516.
3. “Identification of novel antitubulin agents by using a virtual screening approach based on a 7-point pharmacophore model of the tubulin colchi-site.” Massarotti, A.; Theeramunkong, S.; Mesenzani, O.; et al., Chem. Biol. Drug Des. 2011, 78(6), 913-922.
4. “Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize a potent rigid combretastatin analogues.” Theeramunkong S.; Caldarelli, A.; Massarotti, A.; et al., J. Med. Chem., 2011, 54, 4977-4986.

 

งานวิจัยที่นำเสนอ :

1. “Design, synthesis and biological evaluation of novel antitubulinic agents” Theeramunkong, S. EFMC-ISMC 2012 22nd International Symposium on Medicinal Chemistry, September, 2-6, 2012 Berlin, Germany.
2. “Design and synthesis of novel potent antitubulinic agents” Theeramunkong, S. European school of medicinal chemistry 2012, July, 2-7, 2012 Urbino, Italy.
3. “Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.” Theeramunkong S. 4th International Symposium on Advances in Synthetic and Medicinal Chemistry, ASMC11, August 21-25, 2011, St. Petersburg, Russia.
4. “Dipeptidyl peptidase IV inhibitors from structure-based design using scaffold derived from herbal active component.” Theeramunkong S. International Symposium on Medicinal Chemistry, August 31 - September 4, 2008, Vienna, Austria.
5. “Design and synthesis of dipeptidyl peptidase IV Inhibitors as potential antiglycemic agents” Theeramunkong S. “the Fifth Indochina Conference on Pharmaceutical Sciences”, November 21-24, 2007, Bangkok, Thailand.